Coronary thrombolysis: prehospital use.
Strong evidence supports the concept that earlier application of fibrinolytic treatment can maximize the benefits derived. The results of two level I trials have shown that prehospital thrombolysis is feasible and safe. Although the trials have not proven that prehospital thrombolysis improves prognosis, they have shown that early identification of eligible patients can greatly accelerate the process of drug administration.
Theroux
P
P
D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008952:Mobile Health Units; D009203:Myocardial Infarction / Q000188:drug therapy*; D011379:Prognosis; D015912:Thrombolytic Therapy; D013997:Time Factors
D005343:Fibrinolytic Agents